Migraine - Nursing Case Study

Pathophysiology

• Primary mechanism: Migraine is primarily driven by cortical spreading depression (CSD), a wave of neuronal depolarization followed by suppression, which triggers changes in blood flow and activates the trigeminovascular system, leading to inflammation and pain.

• Secondary mechanism: Activation of the trigeminovascular system releases neuropeptides like CGRP (calcitonin gene-related peptide), causing vasodilation and further promoting inflammation in the meninges, contributing to the throbbing headache typical of migraines.

• Key complication: Chronic migraines can lead to medication overuse headaches, where frequent use of pain relief medications paradoxically increases headache frequency and severity, complicating long-term management.

Patient Profile

Demographics:

35-year-old female, graphic designer

History:

• Key past medical history: History of episodic migraines for 5 years, hypertension

• Current medications: Sumatriptan as needed, Lisinopril 10 mg daily

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Persistent headache worsening over the past week

• Key symptoms: Throbbing headache on one side, nausea, sensitivity to light and sound, occasional visual disturbances, neck stiffness

• Vital signs: Blood pressure 150/95 mmHg, heart rate 92 bpm, respiratory rate 18 breaths per minute, temperature 98.9°F

Section 1

As the patient's headache persisted and intensified, she returned to the clinic for further evaluation. During the initial assessment, the nurse noted that the patient appeared fatigued and slightly diaphoretic. Her vital signs showed a blood pressure of 155/98 mmHg, indicating a slight increase from her previous reading, while her heart rate remained at 92 bpm, and her respiratory rate was stable at 18 breaths per minute. The patient reported that her usual dose of Sumatriptan was no longer effective in alleviating her symptoms. Further examination revealed increased neck stiffness and tenderness upon palpation, raising concerns about potential complications such as cervicogenic headache or meningitis.

The nurse practitioner ordered a complete blood count (CBC) and a metabolic panel to further investigate underlying causes that might be contributing to her worsening condition. The CBC results showed an elevated white blood cell count of 12,000 cells/mcL, suggesting a potential inflammatory or infectious process, although the lack of fever made an acute infection less likely. Electrolyte levels were within normal limits, but mild dehydration was suspected based on the patient's reported nausea and reduced oral intake.

Given the clinical findings and the patient's history of migraine with current medication use, the healthcare team considered the possibility of medication overuse headache, which often complicates chronic migraine management. The team discussed adjusting her treatment plan to include preventive options such as beta-blockers or topiramate to reduce migraine frequency and severity. They also emphasized the importance of hydration and reviewed non-pharmacological strategies like stress reduction and consistent sleep patterns to help manage her condition. The patient was advised to follow up in a week to evaluate the effectiveness of the new management approach and to report any additional symptoms immediately.

Section 2

A week after the initial assessment and adjustment of her treatment regimen, the patient returned to the clinic for a follow-up evaluation. During this visit, she reported experiencing some relief in the intensity of her headaches, though they had not completely subsided. However, she now noticed intermittent episodes of dizziness and occasional palpitations. The nurse conducted a thorough assessment, noting the patient's vital signs: blood pressure at 140/88 mmHg, heart rate slightly elevated at 102 bpm, and respiratory rate stable at 18 breaths per minute. The nurse also observed mild pallor and noted that the patient appeared more anxious than before.

Given these new symptoms, the healthcare team decided to investigate further. An ECG was performed, revealing occasional premature ventricular contractions, which could be related to the new beta-blocker therapy. Additionally, the nurse practitioner ordered a follow-up metabolic panel. The results indicated a slight decrease in sodium levels, suggesting a potential side effect of the medication or inadequate fluid intake. The patient was encouraged to increase her hydration and to monitor her diet closely for adequate electrolyte intake.

The healthcare team considered the possibility of the new medication contributing to the patient's symptoms and decided to adjust her beta-blocker dosage while closely monitoring her cardiac status. They emphasized the importance of continuing preventive strategies alongside lifestyle modifications. The patient was advised to maintain a symptom diary to track her headaches, dizziness, and any palpitations, which would assist in further refining her treatment plan. A follow-up appointment was scheduled in two weeks to reassess her response to these changes and ensure stabilization of her condition.

Section 3

Two weeks later, the patient returned to the clinic, reporting that her headaches had further diminished in intensity but were still present. However, she expressed concern over persistent dizziness and a new sensation of fatigue, which she described as overwhelming and constant. During this visit, the nurse conducted a comprehensive assessment. The patient's blood pressure was now slightly elevated at 142/90 mmHg, with a heart rate of 98 bpm. Her respiratory rate remained stable at 18 breaths per minute, but the nurse noted an increased level of anxiety and continued mild pallor.

The healthcare team reviewed the patient's symptom diary, which revealed a pattern of dizziness correlating with periods of low fluid intake and inadequate meals. This prompted a more detailed nutritional assessment, revealing that the patient had inadvertently reduced her sodium and caloric intake due to concerns over her blood pressure. The follow-up metabolic panel showed a further decrease in sodium to 131 mmol/L, indicating a more pronounced hyponatremia. This lab finding, coupled with her symptoms, suggested the need for an intervention focused on dietary education and possible adjustment of her medication regimen.

Given these findings, the healthcare team decided to adjust the beta-blocker dosage further and initiated a detailed dietary plan to stabilize her sodium levels. They also recommended incorporating small, frequent meals to manage her energy levels and advised her to maintain adequate hydration. The patient was educated on the importance of balancing her diet with her medication regimen to prevent further complications. A close follow-up was scheduled for one week, aiming to reassess her electrolyte balance and ensure that her symptoms were improving with the new dietary and medication adjustments. This approach aimed to prevent further complications and optimize her overall treatment plan.

Section 4

During the follow-up appointment a week later, the patient reported feeling slightly more energetic, although the dizziness persisted intermittently. The dietary adjustments had been challenging for her to adhere to consistently, but she made a concerted effort to maintain better hydration and increased her sodium intake as advised. Despite these efforts, her blood pressure remained elevated, recorded at 145/92 mmHg, and her heart rate was 96 bpm. Importantly, her symptom diary indicated a continued correlation between dizziness episodes and periods of inadequate hydration and nutrition.

The healthcare team reviewed the patient's updated metabolic panel, which showed a modest improvement in sodium levels to 134 mmol/L, suggesting a partial response to dietary changes. However, new lab results revealed a slight increase in serum creatinine to 1.3 mg/dL, from a baseline of 1.0 mg/dL, raising concerns about potential renal implications possibly exacerbated by the ongoing medication regimen. Additionally, the patient's hemoglobin levels were noted to be at the lower end of normal, at 11.5 g/dL, which could contribute to her persistent fatigue.

Given these findings, the team decided to adjust the treatment plan. They reduced the beta-blocker dosage further to alleviate potential renal strain, while also considering the introduction of an angiotensin receptor blocker (ARB) to better manage her blood pressure without compromising kidney function. The patient was counseled on the importance of strictly adhering to the dietary and hydration guidelines and was referred to a nutritionist for more comprehensive support. A re-evaluation was scheduled for two weeks to closely monitor changes in her renal function and overall symptomatology, while also ensuring that her migraine management remained effective without introducing new complications. This strategic adjustment aimed to optimize her treatment and prevent further deterioration of her condition.

Section 5

Two weeks later, during the follow-up appointment, the patient reported a mixed response to the adjusted treatment plan. She experienced a slight reduction in the frequency and intensity of her migraines, which she attributed to better adherence to dietary guidelines and the new medication regimen. However, she noted a new complication: episodes of mild ankle swelling, particularly towards the end of the day. Her blood pressure was recorded at 138/88 mmHg, indicating some improvement, but her heart rate had increased to 102 bpm. Despite these changes, she continued to experience intermittent dizziness, primarily during periods of physical exertion.

The healthcare team reviewed the latest lab results, which showed a stable serum creatinine level at 1.3 mg/dL, suggesting that the renal function had not deteriorated further. However, her sodium level remained at 134 mmol/L, indicating ongoing challenges with maintaining electrolyte balance. The hemoglobin level had slightly decreased to 11.2 g/dL, raising concerns about possible anemia contributing to her fatigue and dizziness. Additionally, a new finding on her metabolic panel revealed a slight increase in BUN to 22 mg/dL, which could suggest a mild degree of dehydration or early signs of kidney strain.

In response to these developments, the team discussed potential adjustments to her treatment plan. They considered the possibility of further tweaking her medication, possibly switching from the beta-blocker to a calcium channel blocker to address the edema and heart rate concerns. Given the persistent electrolyte imbalance and hemoglobin decline, a referral to a hematologist was deemed necessary to rule out any underlying hematological disorders. Furthermore, the patient was educated on recognizing signs of potential complications, such as increased swelling or significant changes in urine output, to ensure prompt intervention if needed. This ongoing collaborative approach aimed to stabilize her condition while minimizing adverse effects associated with her current treatment strategy.